Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling
Publication
, Journal Article
RACIOPPI, L
Published in: J Exp Med
1993
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Exp Med
DOI
Publication Date
1993
Volume
177
Start / End Page
1047 / 1060
Citation
APA
Chicago
ICMJE
MLA
NLM
RACIOPPI, L. (1993). Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J Exp Med, 177, 1047–1060. https://doi.org/10.1084/jem.177.4.1047
RACIOPPI, L. “Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.” J Exp Med 177 (1993): 1047–60. https://doi.org/10.1084/jem.177.4.1047.
RACIOPPI, L. “Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.” J Exp Med, vol. 177, 1993, pp. 1047–60. Cinii-english, doi:10.1084/jem.177.4.1047.
Published In
J Exp Med
DOI
Publication Date
1993
Volume
177
Start / End Page
1047 / 1060